SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported) February 1, 1999
PHARMACEUTICAL MARKETING SERVICES INC.
(Exact Name of Registrant as Specified in Charter)
Delaware 01-9723 51-0335521
(State or Other Jurisdiction (Commission (I.R.S. Employer
of Incorporation) File Number) Identification No.)
Suite 912, 45 Rockefeller Plaza, New York, NY 10111
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number, including area code (212)841-0610
(Former Name or Former Address, if Changed Since Last Report)
<PAGE>
Item 5. Other Events.
On February 1, 1999 the registrant, Pharmaceutical Marketing Services
Inc. (the "Company"), redeemed an aggregate $49.325 million of its 6-1/4%
Convertible Subordinated Debentures due 2003 for $50.866 million, representing
all the remaining outstanding Debentures, at par, plus accrued interest. As a
result, the Company's cash balance has decreased by such amount and the
liability with respect to the Debentures has been eliminated from the Company's
balance sheet.
2
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
PHARMACEUTICAL MARKETING SERVICES INC.
By: /s/ Warren J. Hauser
Name: Warren J. Hauser
Title: Vice President, Secretary
Date: February 12, 1999
3
